# OnCo record rinzimetostat (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rinzimetostat/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rinzimetostat" ;
  schema:name "Rinzimetostat"@en ;
  schema:description "Rinzimetostat is an experimental small-molecule drug from ORIC Pharmaceuticals in phase 3 trials for prostate cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/rinzimetostat/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=ORIC-944>, <https://oricpharma.com/pipeline/> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:companies <https://onco.cc/companies/oric-pharmaceuticals/> ;
  onco:trials <https://onco.cc/trials/himalayas-1/> .